Biogen | Marketskapitalisme



Market Capitalization Endring Dato
AbbVie USD 347.61B 23.02B 2025-05
ALKERMES USD 4.95B 295M 2025-05
Amgen USD 150.06B 10.09B 2025-05
Biogen USD 17.89B 4.39B 2025-05
BioMarin Pharmaceutical USD 11.72B 824M 2025-05
Bristol-Myers Squibb USD 101.45B 22.65B 2025-05
Eli Lilly USD 784.52B 42.86B 2025-05
Gilead Sciences USD 129.47B 10.21B 2025-05
Incyte USD 13.94B 2.22B 2025-05
Merck USD 212.34B 13.54B 2025-05
Moderna USD 10.56B 396M 2025-05
Neurocrine Biosciences USD 13.82B 2.18B 2024-12
Novartis CHF 194.25B 18.5B 2024-12
Pfizer USD 137.09B 6.62B 2025-05
PTC Therapeutics USD 3.51B 653M 2024-12
Regeneron Pharmaceuticals USD 66.6B 2.74B 2025-05
Sanofi EUR 122.48B 3.37B 2025-05
Sarepta Therapeutics USD 11.78B 128M 2024-12
Teva Pharmaceutical Industries ILS 91.91B 16.81B 2024-12
Ultragenyx Pharmaceutical USD 3.88B 1.24B 2024-12
United Therapeutics USD 13.91B 17M 2025-05
Vertex Pharmaceuticals USD 103.45B 16.4B 2024-12



Biogen Marketskapitalisme - Gjeldende verdier, historiske data, prognoser, statistikk, diagrammer og økonomiske kalender - May 2025.